# [18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer

> **NCT02297386** · PHASE1 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Prostate Cancer
- Localized Prostate Cancer

## Interventions

- **DRUG:** [18F] DIHYDRO-TESTOSTERONE
- **DEVICE:** PET scan
- **DEVICE:** MRI
- **OTHER:** Blood draw

## Key facts

- **NCT ID:** NCT02297386
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-11
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2018-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02297386

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02297386, "[18F] Dihydro-testosterone Pet and MR Imaging In Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02297386. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*